ONE YEAR VISUAL RESULTS AFTER INTRAVITREAL BEVACIZUMAB FOR MACULAR EDEMA SECONDARY TO BRANCH RETINAL VEIN OCCLUSION

Parvez Ahmad Handoo; Masarat Nowshad

Volume : VI, Issue : VII, July - 2016

ONE YEAR VISUAL RESULTS AFTER INTRAVITREAL BEVACIZUMAB FOR MACULAR EDEMA SECONDARY TO BRANCH RETINAL VEIN OCCLUSION

Parvez Ahmad Handoo, Masarat Nowshad

Abstract :

Purpose: To determine the effect of intravitreal bevacizumab on visual acuity in patients with macular edema secondary to anch retinal vein occlusion. Material and Methods: This prospective non–randomized clinical interventional study with Convenience (Non Probability) sampling was conducted at SMHS Hospital, Srinagar; from May 2013 to June 2014. Twenty eyes of twenty patients received a single injection of Bevacizumab in a dose of 1.25 mg/0.05 ml. The visual acuity was measured pre injection and at 4, 8 and 12 weeks post injection using Snellen’s visual acuity chart. Results: At presentation 50% of the patients presented with best corrected visual acuity of 6/60 or worse, 35% were in between 6/60 and 6/24 where as 15 % were 6/18 or better. On the 3rd post injection follow up month 5% of the patients were with best corrected visual acuity of 6/60 or worse , 30 % were in between 6/60 and 6/24 where as 65% were 6/18 or better. The results are statistically significant (p value less than 0.05). Conclusions: Intravitreal therapy using bevacizumab appears to be an effective treatment for improvement of vision in patients with macular oedema secondary to anch retinal vein occlusion. The positive results though based on short term basis, encourage studies to be conducted on a longer follow up period.